Found: 45
Select item for more details and to access through your institution.
5q21 deletion is often heterogeneous in prostate cancer.
- Published in:
- Genes, Chromosomes & Cancer, 2019, v. 58, n. 8, p. 509, doi. 10.1002/gcc.22730
- By:
- Publication type:
- Article
13q deletion is linked to an adverse phenotype and poor prognosis in prostate cancer.
- Published in:
- Genes, Chromosomes & Cancer, 2018, v. 57, n. 10, p. 504, doi. 10.1002/gcc.22645
- By:
- Publication type:
- Article
Upregulation of the transcription factor TFAP2D is associated with aggressive tumor phenotype in prostate cancer lacking the TMPRSS2:ERG fusion.
- Published in:
- Molecular Medicine, 2020, v. 26, n. 1, p. 1, doi. 10.1186/s10020-020-00148-4
- By:
- Publication type:
- Article
High concordance of findings obtained from transgluteal magnetic resonance imaging - and transrectal ultrasonography-guided biopsy as compared with prostatectomy specimens.
- Published in:
- BJU International, 2017, v. 120, n. 3, p. 365, doi. 10.1111/bju.13840
- By:
- Publication type:
- Article
Author Correction: Up regulation and nuclear translocation of Y-box binding protein 1 (YB-1) is linked to poor prognosis in ERG-negative prostate cancer.
- Published in:
- Scientific Reports, 2018, v. 8, n. 1, p. 1, doi. 10.1038/s41598-018-30975-9
- By:
- Publication type:
- Article
High-Level γ-Glutamyl-Hydrolase (GGH) Expression is Linked to Poor Prognosis in ERG Negative Prostate Cancer.
- Published in:
- International Journal of Molecular Sciences, 2017, v. 18, n. 2, p. 286, doi. 10.3390/ijms18020286
- By:
- Publication type:
- Article
VEGFR-1 Overexpression Identifies a Small Subgroup of Aggressive Prostate Cancers in Patients Treated by Prostatectomy.
- Published in:
- International Journal of Molecular Sciences, 2015, v. 16, n. 4, p. 8591, doi. 10.3390/ijms16048591
- By:
- Publication type:
- Article
High BCAR1 expression is linked to adverse tumour features and early PSA recurrence in ERG negative prostate cancers.
- Published in:
- Canadian Journal of Pathology, 2016, v. 8, p. 14
- By:
- Publication type:
- Article
High BCAR1 expression is associated with early PSA recurrence in ERG negative prostate cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
High concordance of TMPRSS-ERG fusion between primary prostate cancer and its lymph node metastases.
- Published in:
- Oncology Letters, 2018, v. 16, n. 5, p. 6238, doi. 10.3892/ol.2018.9417
- By:
- Publication type:
- Article
Deletion of 3p13 is a late event linked to progression of <em>TMPRSS2:ERG</em> fusion prostate cancer.
- Published in:
- Cancer Management & Research, 2018, v. 10, p. 5909, doi. 10.2147/CMAR.S172637
- By:
- Publication type:
- Article
Expression of CCCTC‐binding factor (CTCF) is linked to poor prognosis in prostate cancer.
- Published in:
- Molecular Oncology, 2020, v. 14, n. 1, p. 129, doi. 10.1002/1878-0261.12597
- By:
- Publication type:
- Article
High lysophosphatidylcholine acyltransferase 1 expression independently predicts high risk for biochemical recurrence in prostate cancers.
- Published in:
- Molecular Oncology, 2013, v. 7, n. 6, p. 1001, doi. 10.1016/j.molonc.2013.07.009
- By:
- Publication type:
- Article
Epithelial splicing regulatory protein 1 and 2 (ESRP1 and ESRP2) upregulation predicts poor prognosis in prostate cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Upregulation of PTTG1 is associated with poor prognosis in prostate cancer.
- Published in:
- Pathology International, 2020, v. 70, n. 7, p. 441, doi. 10.1111/pin.12938
- By:
- Publication type:
- Article
Up regulation of the Hippo signalling effector YAP1 is linked to early biochemical recurrence in prostate cancers.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-65772-w
- By:
- Publication type:
- Article
Claudin-1 upregulation is associated with favorable tumor features and a reduced risk for biochemical recurrence in ERG-positive prostate cancer.
- Published in:
- World Journal of Urology, 2020, v. 38, n. 9, p. 2185, doi. 10.1007/s00345-019-03017-w
- By:
- Publication type:
- Article
Up regulation and nuclear translocation of Y-box binding protein 1 (YB-1) is linked to poor prognosis in ERG-negative prostate cancer.
- Published in:
- Scientific Reports, 2017, v. 7, n. 1, p. 1, doi. 10.1038/s41598-017-02279-x
- By:
- Publication type:
- Article
FOXA1 expression is a strong independent predictor of early PSA recurrence in ERG negative prostate cancers treated by radical prostatectomy.
- Published in:
- Carcinogenesis, 2017, v. 38, n. 12, p. 1180, doi. 10.1093/carcin/bgx105
- By:
- Publication type:
- Article
Up-regulation of mismatch repair genes MSH6, PMS2 and MLH1 parallels development of genetic instability and is linked to tumor aggressiveness and early PSA recurrence in prostate cancer.
- Published in:
- Carcinogenesis, 2017, v. 38, n. 1, p. 19, doi. 10.1093/carcin/bgw116
- By:
- Publication type:
- Article
Overexpression of enhancer of zeste homolog 2 (EZH2) characterizes an aggressive subset of prostate cancers and predicts patient prognosis independently from pre- and postoperatively assessed clinicopathological parameters.
- Published in:
- Carcinogenesis, 2015, v. 36, n. 11, p. 1333, doi. 10.1093/carcin/bgv137
- By:
- Publication type:
- Article
Upregulation of Phosphatase 1 Nuclear-Targeting Subunit (PNUTS) Is an Independent Predictor of Poor Prognosis in Prostate Cancer.
- Published in:
- Disease Markers, 2020, p. 1, doi. 10.1155/2020/7050146
- By:
- Publication type:
- Article
Upregulation of Phosphatase 1 Nuclear-Targeting Subunit (PNUTS) Is an Independent Predictor of Poor Prognosis in Prostate Cancer.
- Published in:
- Disease Markers, 2020, p. 1, doi. 10.1155/2020/7050146
- By:
- Publication type:
- Article
Immune Exclusion Is Frequent in Small-Cell Carcinoma of the Bladder.
- Published in:
- Disease Markers, 2019, p. 1, doi. 10.1155/2019/2532518
- By:
- Publication type:
- Article
Increased Cytoplasmic CD138 Expression Is Associated with Aggressive Characteristics in Prostate Cancer and Is an Independent Predictor for Biochemical Recurrence.
- Published in:
- BioMed Research International, 2020, p. 1, doi. 10.1155/2020/5845374
- By:
- Publication type:
- Article
Loss of PSP94 expression is associated with early PSA recurrence and deteriorates outcome of PTEN deleted prostate cancers.
- Published in:
- Cancer Biology & Medicine, 2019, v. 16, n. 2, p. 319, doi. 10.20892/j.issn.2095-3941.2018.0384
- By:
- Publication type:
- Article
The prognostic value of SUMO1/Sentrin specific peptidase 1 (SENP1) in prostate cancer is limited to ERG-fusion positive tumors lacking PTEN deletion.
- Published in:
- BMC Cancer, 2015, v. 15, n. 1, p. 1, doi. 10.1186/s12885-015-1555-8
- By:
- Publication type:
- Article
The prognostic value of SUMO1/Sentrin specific peptidase 1 (SENP1) in prostate cancer is limited to ERG-fusion positive tumors lacking PTEN deletion
- Published in:
- BMC Cancer, 2015, v. 15, n. 1, p. 538, doi. 10.1186/s12885-015-1555-8
- By:
- Publication type:
- Article
The prognostic value of SUMO1/Sentrin specific peptidase 1 (SENP1) in prostate cancer is limited to ERG-fusion positive tumors lacking PTEN deletion.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Secreted Frizzled-Related Protein 4 (SFRP4) Is an Independent Prognostic Marker in Prostate Cancers Lacking TMPRSS2: ERG Fusions.
- Published in:
- Pathology & Oncology Research, 2020, v. 26, n. 4, p. 2709, doi. 10.1007/s12253-020-00861-9
- By:
- Publication type:
- Article
Qualitative and Quantitative Requirements for Assessing Prognostic Markers in Prostate Cancer.
- Published in:
- Microarrays (2076-3905), 2014, v. 3, n. 2, p. 137, doi. 10.3390/microarrays3020137
- By:
- Publication type:
- Article
Chromosome 5 harbors two independent deletion hotspots at 5q13 and 5q21 that characterize biologically different subsets of aggressive prostate cancer.
- Published in:
- International Journal of Cancer, 2021, v. 148, n. 3, p. 748, doi. 10.1002/ijc.33344
- By:
- Publication type:
- Article
Expression of DNA ligase IV is linked to poor prognosis and characterizes a subset of prostate cancers harboring TMPRSS2:ERG fusion and PTEN deletion.
- Published in:
- Oncology Reports, 2015, v. 34, n. 3, p. 1211, doi. 10.3892/or.2015.4080
- By:
- Publication type:
- Article
High-level expression of protein tyrosine phosphatase non-receptor 12 is a strong and independent predictor of poor prognosis in prostate cancer.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Loss of CCAAT‐enhancer‐binding protein alpha (CEBPA) is linked to poor prognosis in PTEN deleted and TMPRSS2:ERG fusion type prostate cancers.
- Published in:
- Prostate, 2019, v. 79, n. 3, p. 302, doi. 10.1002/pros.23736
- By:
- Publication type:
- Article
Cytoplasmic accumulation of ELAVL1 is an independent predictor of biochemical recurrence associated with genomic instability in prostate cancer.
- Published in:
- Prostate, 2016, v. 76, n. 3, p. 259, doi. 10.1002/pros.23120
- By:
- Publication type:
- Article
NY-ESO-1 expression is tightly linked to TMPRSS2-ERG fusion in prostate cancer.
- Published in:
- Prostate, 2014, v. 74, n. 10, p. 1012, doi. 10.1002/pros.22816
- By:
- Publication type:
- Article
SPINK1 expression is tightly linked to 6q15- and 5q21-deleted ERG-fusion negative prostate cancers but unrelated to PSA recurrence.
- Published in:
- Prostate, 2013, v. 73, n. 15, p. 1690, doi. 10.1002/pros.22707
- By:
- Publication type:
- Article
Reduced AZGP1 expression is an independent predictor of early PSA recurrence and associated with ERG-fusion positive and PTEN deleted prostate cancers.
- Published in:
- International Journal of Cancer, 2016, v. 138, n. 5, p. 1199, doi. 10.1002/ijc.29860
- By:
- Publication type:
- Article
Concurrent deletion of 16q23 and PTEN is an independent prognostic feature in prostate cancer.
- Published in:
- International Journal of Cancer, 2015, v. 137, n. 10, p. 2354, doi. 10.1002/ijc.29613
- By:
- Publication type:
- Article
The prognostic impact of high Nijmegen breakage syndrome (NBS1) gene expression in ERG-negative prostate cancers lacking PTEN deletion is driven by KPNA2 expression.
- Published in:
- International Journal of Cancer, 2014, v. 135, n. 6, p. 1399, doi. 10.1002/ijc.28778
- By:
- Publication type:
- Article
High-Level HOOK3 Expression Is an Independent Predictor of Poor Prognosis Associated with Genomic Instability in Prostate Cancer.
- Published in:
- PLoS ONE, 2015, v. 10, n. 7, p. 1, doi. 10.1371/journal.pone.0134614
- By:
- Publication type:
- Article
Loss of SOX9 Expression Is Associated with PSA Recurrence in ERG-Positive and PTEN Deleted Prostate Cancers.
- Published in:
- PLoS ONE, 2015, v. 10, n. 6, p. 1, doi. 10.1371/journal.pone.0128525
- By:
- Publication type:
- Article
Heterogeneity of ERG expression in prostate cancer: a large section mapping study of entire prostatectomy specimens from 125 patients.
- Published in:
- 2016
- By:
- Publication type:
- journal article
High mitochondria content is associated with prostate cancer disease progression.
- Published in:
- Molecular Cancer, 2013, v. 12, n. 1, p. 1, doi. 10.1186/1476-4598-12-145
- By:
- Publication type:
- Article